中文产业新闻精选评分79Chinese source
诺华remibrutinib获FDA批准用于成人症状性皮肤划痕症，适应症由CSU拓展至慢性诱导性荨麻疹
诺华首款症状性皮肤划痕症靶向药物获FDA批准，BTK抑制剂拓展至慢性诱导性荨麻疹
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
诺华首款症状性皮肤划痕症靶向药物获FDA批准，BTK抑制剂拓展至慢性诱导性荨麻疹
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.